Recent studies have explored the role of miR-21 in response to various drugs and suggested that miR-21 could promote chemoresistance in NSCLC through negative regulation of PTEN and PDCD4; consequently activating the Akt/Erk pathway [15,19]. Here, AKT1 is linked to non-small cell lung carcinoma.